Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02793947 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Peri-Incisional Multimodal Drug Injection Following Operative Management of Femur Fractures
A Phase 4 study, sponsored by University of Iowa.
- Completed
- Registry status
- Phase 4
- Development phase
- 102
- Enrollment target
NCT02793947 is a Phase 4 study that has completed, run by University of Iowa. The registered enrollment target is 102 participants.
The verdict
NCT02793947, a Phase 4 study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 102 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the efficacy and safety of a peri-incisional multimodal injection for post-operative pain control following operative management of femur fractures. Enrolled subjects will be prospectively randomized into either the peri-incisional injection or control cohorts. Patients will be treated with standard of care surgical techniques by the treating orthopaedic surgeon for the patient's specific fracture pattern. The patients randomized into the injection cohort will receive an intra-operative injection with 400 mg ropivacaine, 0.6 mg epinephrine, 5 mg and morphine into the local superficial and deep peri-incisional tissues while under general anesthesia. Visual analog pain scores will be collected every 4 hours after surgery for the first two post-operative days. Total narcotic consumption will also be recorded over eight hour intervals for the first two post-operative days. Medication related side effects will be monitored. The investigators hypothesize that the peri-incisional injection cohort will demonstrate an improved pain profile and utilize less parenteral narcotic analgesia in the early post-operative period.
Interventions
- DRUG Epinephrine
- DRUG Ropivacaine
- DRUG Morphine
- DRUG 0.9% sodium chloride solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 102 participants |
| Start Date | 2015-05 |
| Est. Completion | 2016-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02793947
The ClinicalTrials.gov registry entry for NCT02793947 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 102 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Epinephrine is the first listed.
NCT02793947 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02793947 about?
NCT02793947 is a clinical study titled "Efficacy of Peri-Incisional Multimodal Drug Injection Following Operative Management of Femur Fractures". The purpose of this study is to determine the efficacy and safety of a peri-incisional multimodal injection for post-operative pain control following operative management of femur fractures. Enrolled subjects will be prospectively randomized into either the peri-incisional injection or control cohor...
What is the current status of trial NCT02793947?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 102 participants. The study started on 2015-05. Estimated completion is 2016-08.
What interventions are being tested in trial NCT02793947?
The interventions under investigation include: Epinephrine (DRUG), Ropivacaine (DRUG), Morphine (DRUG), 0.9% sodium chloride solution (DRUG).
Who is sponsoring clinical trial NCT02793947?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.